A detailed history of Magellan Asset Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Magellan Asset Management LTD holds 980 shares of LLY stock, worth $733,049. This represents 0.01% of its overall portfolio holdings.

Number of Shares
980
Previous 984 0.41%
Holding current value
$733,049
Previous $890,000 2.47%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $3,088 - $3,840
-4 Reduced 0.41%
980 $868,000
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $120,328 - $150,900
-166 Reduced 14.43%
984 $890,000
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $681,030 - $911,122
1,150 New
1,150 $894,000
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $25,672 - $32,085
-299 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $2,894 - $3,416
39 Added 15.0%
299 $23,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $21,304 - $22,851
260
260 $22,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Magellan Asset Management LTD Portfolio

Follow Magellan Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magellan Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Magellan Asset Management LTD with notifications on news.